UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 6.664

Sortiert nach

Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry

Drug metabolism and disposition, 2014-12, Vol.42 (12), p.2023

2014

Volltextzugriff (PDF)

The Developmental Origins of a Disposition Toward Empathy: Genetic and Environmental Contributions

Emotion (Washington, D.C.), 2008-12, Vol.8 (6), p.737-752

2008

Volltextzugriff (PDF)

Hydroxytyrosol Disposition in Humans

Clinical chemistry (Baltimore, Md.), 2003-06, Vol.49 (6), p.945-952

2003

Volltextzugriff (PDF)

Comparing the effects of traditional lecture and flipped classroom on nursing students' critical thinking disposition: A quasi-experimental study

Nurse education today, 2018-12, Vol.71, p.151-156

2018

Volltextzugriff (PDF)

Brivaracetam Disposition in Renal Impairment

Journal of clinical pharmacology, 2012-12, Vol.52 (12), p.1927-1933

2012

Volltextzugriff (PDF)

Disposition, metabolism and mass balance of [14C]apremilast following oral administration

Xenobiotica, 2011-12, Vol.41 (12), p.1063-1075

2011

Volltextzugriff (PDF)

Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions

Pharmaceutical research, 2012-10, Vol.29 (10), p.2860-2873

2012

Volltextzugriff (PDF)

Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease

The Journal of pharmacology and experimental therapeutics, 2015-01, Vol.352 (1), p.110

2015

Volltextzugriff (PDF)

Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites

Drug metabolism and disposition, 2013-06, Vol.41 (6), p.1179

2013

Volltextzugriff (PDF)

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Clinical pharmacology and therapeutics, 2008-08, Vol.84 (2), p.248-253

2008

Volltextzugriff (PDF)

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

Clinical pharmacology and therapeutics, 2007-07, Vol.82 (1), p.33-40

2007

Volltextzugriff (PDF)

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

Drug metabolism and disposition, 2008-02, Vol.36 (2), p.386

2008

Volltextzugriff (PDF)

Intratumoral Estrogen Disposition in Breast Cancer

Clinical cancer research, 2010-03, Vol.16 (6), p.1790-1801

2010

Volltextzugriff (PDF)

The role of personality dispositions to risky behavior in predicting first-year college drinking

Addiction (Abingdon, England), 2009-02, Vol.104 (2), p.193-202

2009

Volltextzugriff (PDF)

Metabolism and disposition of [14C]tivantinib after oral administration to humans, dogs and rats

Xenobiotica, 2014-11, Vol.44 (11), p.996-1008

2014

Volltextzugriff (PDF)

Patient Frailty and Discharge Disposition Following Radical Cystectomy

Clinical genitourinary cancer, 2017-08, Vol.15 (4), p.e615-e621

2017

Volltextzugriff (PDF)

Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites

Drug metabolism and disposition, 2015-08, Vol.43 (8), p.1190-1207

2015

Volltextzugriff (PDF)

Disposition of Atorvastatin, Rosuvastatin, and Simvastatin in Oatp1b2-/- Mice and Intraindividual Variability in Human Subjects

Journal of clinical pharmacology, 2012-11, Vol.52 (11), p.1689-1697

2012

Volltextzugriff (PDF)

Thin-slicing study of the oxytocin receptor (OXTR) gene and the evaluation and expression of the prosocial disposition

Proceedings of the National Academy of Sciences - PNAS, 2011-11, Vol.108 (48), p.19189-19192

2011

Volltextzugriff (PDF)

The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humans

Drug metabolism and disposition, 2010-04, Vol.38 (4), p.667

2010

Volltextzugriff (PDF)

Disposition and metabolism of [14C]SB-649868, an orexin 1 and 2 receptor antagonist, in humans

Drug metabolism and disposition, 2011-02, Vol.39 (2), p.215

2011

Volltextzugriff (PDF)

Population Pharmacokinetic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using a Michaelis–Menten Approximation of a Target-Mediated Drug Disposition Model—Support for a Biologics License Application Submission: Part I

Clinical pharmacokinetics, 2019-01, Vol.58 (1), p.101-113

2019

Volltextzugriff (PDF)

Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates

Clinical pharmacology and therapeutics, 2019-03, Vol.105 (3), p.719-729

2019

Volltextzugriff (PDF)

CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

Clinical pharmacology and therapeutics, 2006-11, Vol.80 (5), p.457-467

2006

Volltextzugriff (PDF)

1 – 25 von 6.664

Suche als RSS-Feed

Aktive Filter

KollektionSociological Abstracts

Zeitschrift / SerieBiopharmaceutics & Drug Disposition

Zeitschrift / SeriePlos One

Zeitschrift / SerieThe American Journal Of Emergency Medicine

SpracheJapanisch

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.453)
Mit Volltextzugriff
(5.665)

Publikationsform

Artikel
(6.663)
Buchkapitel
(1)

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(6.657)
Science & Technology
(5.859)
Life Sciences & Biomedicine
(5.785)
Male
(5.722)
Female
(5.277)
Middle Aged
(3.951)
Biological And Medical Sciences
(3.061)
Medical Sciences
(2.687)
Aged
(2.305)
Pharmacology & Pharmacy
(2.038)
Adolescent
(1.776)
Pharmacology. Drug Treatments
(1.544)
Young Adult
(1.539)
Aged, 80 And Over
(818)
Treatment Outcome
(788)
Pharmacology
(705)
Social Sciences
(690)
Psychology. Psychoanalysis. Psychiatry
(687)
Psychology
(677)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry

The Developmental Origins of a Disposition Toward Empathy: Genetic and Environmental Contributions

Hydroxytyrosol Disposition in Humans

Comparing the effects of traditional lecture and flipped classroom on nursing students' critical thinking disposition: A quasi-experimental study

Brivaracetam Disposition in Renal Impairment

Disposition, metabolism and mass balance of [14C]apremilast following oral administration

Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions

Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease

Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Fertility patients' views about frozen embryo disposition: results of a multi-institutional U.S. survey

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

Intratumoral Estrogen Disposition in Breast Cancer

The role of personality dispositions to risky behavior in predicting first-year college drinking

Metabolism and disposition of [14C]tivantinib after oral administration to humans, dogs and rats

Patient Frailty and Discharge Disposition Following Radical Cystectomy

Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites

Disposition of Atorvastatin, Rosuvastatin, and Simvastatin in Oatp1b2-/- Mice and Intraindividual Variability in Human Subjects

Thin-slicing study of the oxytocin receptor (OXTR) gene and the evaluation and expression of the prosocial disposition

The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humans

Disposition and metabolism of [14C]SB-649868, an orexin 1 and 2 receptor antagonist, in humans

Population Pharmacokinetic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using a Michaelis–Menten Approximation of a Target-Mediated Drug Disposition Model—Support for a Biologics License Application Submission: Part I

Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates

CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

Aktive Filter

Suchergebnisse filtern